ALT
NASDAQ · Biotechnology
Altimmune Inc
$3.31
+0.07 (+2.16%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+218.7% upside
Low Target
$6.68
Average Target
$10.55
High Target
$11.58
Current Price
$3.31
Current
$3.31
$3.31
Target
$10.55
$10.55
$6.68
$10.55 avg
$11.58
Scenario Analysis
Bear Case
$6.68
101.8%
Low target
Base Case
$10.55
+218.7%
Avg target
Bull Case
$11.58
+249.8%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$7.73
-57.2% from high
52-Week Low
$2.90
+14.1% from low
Target vs 52W High
$10.55
+36.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |